Clinical performance of the IMMY cryptococcal antigen lateral flow assay in dogs and cats.

ABSTRACT:

Background

Cryptococcal lateral flow antigen assays (CLFAs) have been assessed in comparison to the latex cryptococcal antigen agglutination test but their clinical performance is unknown.

Objective

Determine clinical performance of IMMY CLFA (Immuno-Mycologics Inc, Oklahoma) using patients with and without cryptococcosis as the reference standard.

Animals

One-hundred ninety-seven serum samples from client-owned dogs and cats.

Methods

Review of medical records of a referral population of dogs and cats that had CLFA performed between 2012 and 2020. Animals were classified as cryptococcosis positive (Cr+) or negative (Cr-) based on clinical information. Clinical diagnosis was used to calculate positive and negative percent agreement of the CLFA.

Results

Tw

SUBMITTER: Langner KFA 

PROVIDER: S-EPMC9708421 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature